Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Johannes Gutenberg-Universität Mainz

Saarstr. 21, 55099 Mainz
  • 6131/39-0
Publikationen
Ergebnisse pro Seite:  10


Schafigh, Myriam; Welz, Armin; Hamiko, Marwan et al.

Risk Factors for High Blood Product Use in Patients with Stanford Type A Dissection

THORACIC AND CARDIOVASCULAR SURGEON. Bd. 70. H. 04. 2022 S. 306-313


Riedl, Jana C.; Misirkhanova, Aminat; Musayeva, Aytan et al.

Risk factors for peripheral hypertrophic subepithelial corneal opacification

ACTA OPHTHALMOLOGICA. 2022


Kramer, Andreas; Degenhartt, Xenia; Gutenberg, Angelika et al.

Risk factors for postoperative seizures in patients with chronic subdural haematomas

NEUROSURGICAL REVIEW. Bd. 45. H. 5. 2022 S. 3291-3298


Woelber, Linn; Hampl, Monika; Eulenburg, Christine Zu et al.

Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study

CANCERS. Bd. 14. H. 2. 2022


Wester, Axel; Schoenau, Johanna; Schattenberg, Joern M. et al.

RISK OF FRACTURES AND POST-FRACTURE MORTALITY IN PRIMARY BILIARY CHOLANGITIS: A POPULATION-BASED COHORT STUDY OF 3,980 PATIENTS

HEPATOLOGY. Bd. 76. 2022 S. S1491-S1491


Dudley, Isabelle M.; Sunguc, Ceren; Heymer, Emma J. et al.

Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study

CANCER. Bd. 129. H. 3. 2022 S. 426-440


Sunguc, Ceren; Hawkins, Michael M.; Winter, David L. et al.

Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

BRITISH JOURNAL OF CANCER. Bd. 128. H. 1. 2022 S. 80-90


Kohls, Natascha; Konstantinides, ?; Lang, Irene Marthe et al.

Risk stratification and risk-adapted management of acute pulmonary embolism

WIENER KLINISCHE WOCHENSCHRIFT. 2022


Hess, Connie N.; Szarek, Michael; Anand, Sonia S. et al.

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

JAMA NETWORK OPEN. Bd. 5. H. 6. 2022